Società Albireo Pharma, Inc. Deutsche Boerse AG
Azioni
BDQM
US01345P1066
Biotecnologia
Attività
Numero di dipendenti: 130
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Ronald Cooper
CEO | Chief Executive Officer | 61 | 01/06/15 |
Founder | 60 | 08/12/03 | |
President | 57 | 02/03/23 | |
Joan Connolly
CTO | Chief Tech/Sci/R&D Officer | - | 13/04/21 |
Paul Streck
CTO | Chief Tech/Sci/R&D Officer | 60 | 19/12/22 |
Heather White
CTO | Chief Tech/Sci/R&D Officer | - | 02/03/23 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Corporate Secretary | - | 02/03/23 | |
Michelle Graham
HRO | Human Resources Officer | 57 | 04/11/19 |
Muffy Carter
LAW | General Counsel | 71 | 29/11/16 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 55 | 02/03/23 | |
Director/Board Member | 62 | 02/03/23 | |
Ronald Cooper
CEO | Chief Executive Officer | 61 | 01/06/15 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 20 709 043 | 18 650 831 ( 90,06 %) | 7 760 ( 0,0375 %) | 90,06 % |
Coordinate società
Albireo Pharma, Inc.
53 State Street 19th Floor
02109, Boston
+857 254 5555
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+18,72% | 125 Mrd | |
+14,19% | 108 Mrd | |
-4,93% | 24,21 Mrd | |
+3,23% | 22,78 Mrd | |
-10,44% | 17,96 Mrd | |
-41,74% | 16,43 Mrd | |
-13,31% | 16,37 Mrd | |
+2,44% | 13,58 Mrd | |
+27,89% | 11,66 Mrd |